Cardiac troponin I: A new tool for prognostic risk assessment

This application note explores the expanded clinical utility of the Atellica^® IM High-Sensitivity Troponin I (TnIH) Assay as an aid in assessing prognosis in patients presenting with suspected acute coronary syndrome (ACS).

Discover how a cardiac troponin I result can provide insight into the risk of all-cause mortality or major adverse cardiac events for up to one year following an emergency department visit. Clinical study data demonstrate the assay’s prognostic performance across multiple follow-up periods, showing how established cardiac biomarker testing can support more informed evaluation and follow-up beyond acute myocardial infarction diagnosis.

Resource details:

Resource type: Application note
Page count: 6
Read time: 9 mins